Begelomab (Anti-DPP4 / CD26)

Ask supplier a question | View on supplier's website

Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2517
Sku #	A2517-1mg*5
Pricing	1mg*5, $1690.00

Feedback